text
"['\n2. 연결재무제표\n가. 연결 재무상태표\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0연 결 재 무 상 태 표\n제35기 1분기 (2023.03.31 현재)\n제34기 \xa0 \xa0 \xa0 \xa0 \xa0(2022.12.31 현재)\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과목\n주석\n제35기 1분기\n제34기\n자산\xa0\n\u3000\n\u3000\n\u3000\n\xa0Ⅰ. 현금및현금성자산\xa0\n4, 6, 12\n267,714,773,438\xa0\n602,036,177,820\xa0\n\xa0Ⅱ. 금융자산\xa0\n\u3000\n31,418,724,817,692\xa0\n33,773,798,109,656\xa0\n\xa0 \xa01. 예치금\xa0\n5, 6, 12\n0\xa0\n436,452,346,260\xa0\n\xa0 \xa02. 당기손익-공정가치측정금융자산\xa0\n5, 6, 12\n7,304,310,946,649\xa0\n0\xa0\n\xa0 \xa03. 당기손익인식금융자산\n5, 6, 12\n0\xa0\n4,416,875,138,818\xa0\n\xa0 \xa04. 기타포괄손익-공정가치측정금융자산\n5, 6, 12\n16,368,577,134,511\xa0\n0\xa0\n\xa0 \xa05. 매도가능금융자산\n5, 6, 12\n0\xa0\n7,909,783,190,958\xa0\n\xa0 \xa06. 상각후원가측정금융자산\n5, 6, 29\n7,695,779,124,537\xa0\n0\xa0\n\xa0 \xa07. 만기보유금융자산\n5, 6, 12\n0\xa0\n13,737,432,694,275\xa0\n\xa0 \xa08. 위험회피목적파생상품자산\xa0\n5, 6\n50,057,611,995\xa0\n186,232,672,665\xa0\n\xa0 \xa09. 대출채권\xa0\n5, 6, 12\n0\xa0\n6,781,823,867,538\xa0\n\xa0 \xa010. 수취채권\xa0\n5, 6, 12\n0\xa0\n305,198,199,142\xa0\n\xa0Ⅲ. 관계기업투자자산\xa0\n7\n100,109,450,096\xa0\n0\xa0\n\xa0Ⅳ. 유형자산\xa0\n8\n66,191,599,945\xa0\n70,942,949,235\xa0\n\xa0Ⅴ. 투자부동산\xa0\n9\n274,857,287,682\xa0\n274,193,609,234\xa0\n\xa0Ⅵ. 무형자산\xa0\n10\n23,056,169,995\xa0\n24,801,360,047\xa0\n\xa0Ⅶ. 기타자산\xa0\n\u3000\n128,943,736,790\xa0\n89,259,452,536\xa0\n\xa0 \xa01. 순확정급여자산\n17\n1,562,862,926\xa0\n4,895,343,798\xa0\n\xa0 \xa02. 당기법인세자산\n28\n111,626,070,698\xa0\n82,310,971,336\xa0\n\xa0 \xa03. 이연법인세자산\n28\n0\xa0\n0\xa0\n\xa0 \xa04. 그밖의기타자산\n11, 29\n15,754,803,166\xa0\n2,053,137,402\xa0\n\xa0Ⅷ. 보험계약자산\xa0\n13\n0\xa0\n0\xa0\n\xa0IX. 재보험계약자산\xa0\n13\n31,416,593,850\xa0\n31,868,571,896\xa0\n자산 총계\n\u3000\n32,311,014,429,488\xa0\n34,866,900,230,424\xa0\n부채\xa0\n\u3000\n\u3000\n\u3000\n\xa0Ⅰ. 보험계약부채\xa0\n13\n26,141,994,719,972\xa0\n26,240,368,974,589\xa0\n\xa0Ⅱ. 재보험계약부채\xa0\n13\n8,380,529,934\xa0\n7,542,004,265\xa0\n\xa0Ⅲ. 투자계약부채\xa0\n\u3000\n2,434,367,458,074\xa0\n2,463,630,677,044\xa0\n\xa0Ⅳ. 계약자지분조정\xa0\n14\n330,025,846\xa0\n793,074,690\xa0\n\xa0Ⅴ. 금융부채\xa0\n\u3000\n568,175,197,390\xa0\n548,540,062,057\xa0\n\xa0 \xa01. 당기손익-공정가치측정금융부채\xa0\n6\n13,573,545,199\xa0\n0\xa0\n\xa0 \xa02. 당기손익인식금융부채\xa0\n6\n0\xa0\n1,658,694,519\xa0\n\xa0 \xa03. 상각후원가측정금융부채\xa0\n6, 15, 29\n340,929,685,927\xa0\n336,931,245,105\xa0\n\xa0 \xa04. 위험회피목적파생상품부채\xa0\n5, 6\n213,671,966,264\xa0\n209,950,122,433\xa0\n\xa0Ⅵ. 기타부채\xa0\n\u3000\n170,561,913,863\xa0\n746,435,633,652\xa0\n\xa0 \xa01. 충당부채\xa0\n16\n27,368,370,700\xa0\n27,454,277,134\xa0\n\xa0 \xa02. 순확정급여부채\n17\n268,723,505\xa0\n135,943,102\xa0\n\xa0 \xa03. 당기법인세부채\xa0\n28\n0\xa0\n313,293,350\xa0\n\xa0 \xa04. 이연법인세부채\xa0\n28\n120,964,813,630\xa0\n681,479,322,517\xa0\n\xa0 \xa05. 그밖의기타부채\xa0\n18\n21,960,006,028\xa0\n37,052,797,549\xa0\n부채 총계\n\u3000\n29,323,809,845,079\xa0\n30,007,310,426,297\xa0\n자본\xa0\n20\n\u3000\n\u3000\n\xa0Ⅰ. 지배주주지분\xa0\n\u3000\n2,987,204,584,409\xa0\n4,859,589,804,127\xa0\n\xa0 \xa01. 자본금\xa0\n\u3000\n806,792,925,000\xa0\n806,792,925,000\xa0\n\xa0 \xa02. 자본잉여금\xa0\n\u3000\n463,680,391,349\xa0\n463,680,391,349\xa0\n\xa0 \xa03. 신종자본증권\xa0\n\u3000\n344,567,360,747\xa0\n344,572,058,588\xa0\n\xa0 \xa04. 연결자본조정\xa0\n\u3000\n-60,666,659,540\xa0\n-60,806,002,790\xa0\n\xa0 \xa05. 연결기타포괄손익누계액\xa0\n5\n230,076,491,506\xa0\n1,526,855,429,597\xa0\n\xa0 \xa06. 연결이익잉여금\xa0\n\u3000\n1,202,754,075,347\xa0\n1,778,495,002,383\xa0\n\xa0Ⅱ. 비지배지분\xa0\n\u3000\n0\xa0\n0\xa0\n자본 총계\n\u3000\n2,987,204,584,409\xa0\n4,859,589,804,127\xa0\n부채 및 자본 총계\n\u3000\n32,311,014,429,488\xa0\n34,866,900,230,424\xa0\n주) 제35기는 2023년부터 적용되는 기업회계기준서 제1117호(보험계약) 및 제1109호(금융상품) 기준으로 작성되었고 제34기는 기업회계기준서 제1117호(보험계약) 및 제1039호(금융상품) 기준으로 작성\n나. 연결포괄손익계산서 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 포 괄 손 익 계 산 서\n제35기 1분기 (2023. 01. 01 ~ 2023. 3. 31)\n제34기 1분기 (2022. 01. 01 ~ 2022. 3. 31)\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과목\n주석\n제35기 1분기\xa0\n제34기 1분기\n\xa0Ⅰ. 순보험서비스손익\n\u3000\n47,301,476,072\xa0\n64,072,530,063\xa0\n\xa0 \xa01. 보험계약의 보험서비스결과\n13, 21\n67,661,285,547\xa0\n72,198,415,099\xa0\n\xa0 \xa0 \xa0(1) 보험수익\n\u3000\n272,613,202,987\xa0\n244,341,038,821\xa0\n\xa0 \xa0 \xa0(2) 보험서비스비용\n\u3000\n-204,951,917,440\xa0\n-172,142,623,722\xa0\n\xa0 \xa02. 재보험계약의 보험서비스결과\n13, 21\n-265,319,182\xa0\n1,061,423,888\xa0\n\xa0 \xa0 \xa0(1) 재보험수익\n\u3000\n7,564,266,128\xa0\n4,254,171,498\xa0\n\xa0 \xa0 \xa0(2) 재보험비용\n\u3000\n-7,829,585,310\xa0\n-3,192,747,610\xa0\n\xa0 \xa03. 기타보험비용\n13, 21\n-20,094,490,293\xa0\n-9,187,308,924\xa0\n\xa0Ⅱ. 순투자손익\xa0\n\u3000\n447,103,327,466\xa0\n178,343,567,229\xa0\n\xa0 \xa01. 투자영업수익\n\u300022, 23, 24, 25, 29\n805,460,978,194\xa0\n489,472,992,113\xa0\n\xa0 \xa0 \xa0(1) 이자수익\xa0\n\u3000\n220,606,229,961\xa0\n207,168,906,845\xa0\n\xa0 \xa0 \xa0(2) 배당수익\xa0\n\u3000\n533,915,592\xa0\n27,625,569,137\xa0\n\xa0 \xa0 \xa0(3) 당기손익-공정가치금융자산관련이익 \xa0\n\u3000\n263,237,080,564\xa0\n0\xa0\n\xa0 \xa0 \xa0(4) 당기손익인식금융자산관련이익\xa0\n\u3000\n0\xa0\n31,354,075,689\xa0\n\xa0 \xa0 \xa0(5) 기타포괄손익-공정가치금융자산관련이익\n\u3000\n1,322,580,708\xa0\n0\xa0\n\xa0 \xa0 \xa0(6) 매도가능금융자산관련이익\xa0\n\u3000\n0\xa0\n36,666,513,444\xa0\n\xa0 \xa0 \xa0(7) 상각후원가측정금융자산관련이익 \xa0\n\u3000\n1,810,548\xa0\n0\xa0\n\xa0 \xa0 \xa0(8) 기대신용손실환입액 \xa0\n\u3000\n13,868,367\xa0\n0\xa0\n\xa0 \xa0 \xa0(9) 손상차손환입\xa0\n\u3000\n0\xa0\n80,639,290\xa0\n\xa0 \xa0 \xa0(10) 외환거래이익\xa0\n\u3000\n216,432,453,121\xa0\n159,275,549,351\xa0\n\xa0 \xa0 \xa0(11) 파생상품관련이익\xa0\n\u3000\n63,431,656,768\xa0\n10,317,286,922\xa0\n\xa0 \xa0 \xa0(12) 수수료손익\xa0\n\u3000\n8,858,177,992\xa0\n4,194,973,254\xa0\n\xa0 \xa0 \xa0(13) 기타투자이익\xa0\n\u3000\n31,023,204,573\xa0\n12,789,478,181\xa0\n\xa0 \xa02. 투자영업비용\n\u300022, 23, 25, 26, 29\n358,357,650,728\xa0\n311,129,424,884\xa0\n\xa0 \xa0 \xa0(1) 이자비용\xa0\n\u3000\n31,962,327,764\xa0\n17,018,778,704\xa0\n\xa0 \xa0 \xa0(2) 당기손익-공정가치금융자산관련손실\n\u3000\n60,417,568,527\xa0\n0\xa0\n\xa0 \xa0 \xa0(3) 당기손익인식금융자산관련손실\n\u3000\n0\xa0\n121,739,256,086\xa0\n\xa0 \xa0 \xa0(4) 기타포괄손익-공정가치금융자산관련손실\n\u3000\n666,656,713\xa0\n0\xa0\n\xa0 \xa0 \xa0(5) 매도가능금융자산관련손실\n\u3000\n0\xa0\n34,442,207,932\xa0\n\xa0 \xa0 \xa0(6) 상각후원가측정금융자산관련손실\n\u3000\n1,664,361\xa0\n0\xa0\n\xa0 \xa0 \xa0(7) 기대신용손실전입액\n\u3000\n625,264,886\xa0\n0\xa0\n\xa0 \xa0 \xa0(8) 손상차손\n\u3000\n0\xa0\n2,203,513,640\xa0\n\xa0 \xa0 \xa0(9) 외환거래손실\n\u3000\n29,057,847,703\xa0\n2,340,194,683\xa0\n\xa0 \xa0 \xa0(10) 파생상품관련손실\n\u3000\n229,925,069,999\xa0\n123,912,155,270\xa0\n\xa0 \xa0 \xa0(11) 재산관리비\n\u3000\n898,912,069\xa0\n961,460,915\xa0\n\xa0 \xa0 \xa0(12) 기타투자손실\n\u3000\n4,802,338,706\xa0\n8,511,857,654\xa0\n\xa0Ⅲ. 순보험금융손익\n\u3000\n-305,233,723,111\xa0\n-154,135,862,641\xa0\n\xa0 \xa0 \xa0(1) 보험계약의 보험금융손익\n22\n-305,420,578,910\xa0\n-154,438,761,948\xa0\n\xa0 \xa0 \xa0(2) 재보험계약의 보험금융손익\n22\n186,855,799\xa0\n302,899,307\xa0\n\xa0Ⅳ. 영업이익\n\u3000\n189,171,080,427\xa0\n88,280,234,651\xa0\n\xa0Ⅴ. 영업외수익\n27\n413,968,967\xa0\n1,093,464,072\xa0\n\xa0Ⅵ. 영업외비용\n27\n632,889,514\xa0\n2,811,180,385\xa0\n\xa0Ⅶ. 법인세비용차감전 손익\n\u3000\n188,952,159,880\xa0\n86,562,518,338\xa0\n\xa0Ⅷ. 법인세비용\n28\n39,380,004,315\xa0\n21,734,225,924\xa0\n\xa0Ⅸ. 연결분기순이익\n\u3000\n149,572,155,565\xa0\n64,828,292,414\xa0\n\xa0Ⅹ. 연결기타포괄손익\xa0\n\u3000\n-144,753,828,303\xa0\n778,308,514,215\xa0\n\xa0 \xa01. 후속적으로 당기손익으로 재분류될 수 있는 포괄손익\n\u3000\n403,031,087,866\xa0\n-427,939,995,119\xa0\n\xa0 \xa0 \xa0(1) 매도가능금융자산평가손익\xa0\n\u3000\n0\xa0\n-424,609,185,693\n\xa0 \xa0 \xa0(2) 만기보유금융자산평가손익\xa0\n\u3000\n0\xa0\n-3,583,302,992\n\xa0 \xa0 \xa0(3) 기타포괄손익-공정가치측정채무증권평가손익\n\u3000\n384,032,501,937\xa0\n0\xa0\n\xa0 \xa0 \xa0(4) 현금흐름위험회피파생상품평가손익\n\u3000\n18,998,585,929\xa0\n252,493,566\xa0\n\xa0 \xa02. 후속적으로 당기손익으로 재분류되지 않는 포괄손익\n\u3000\n-547,784,916,169\xa0\n1,206,248,509,334\xa0\n\xa0 \xa0 \xa0(1) 기타포괄손익-공정가치측정지분증권평가손익\xa0\n\u3000\n-35,831,480\xa0\n0\xa0\n\xa0 \xa0 \xa0(2) 보험금융기타포괄손익\xa0\n\u3000\n-545,077,566,282\xa0\n1,201,248,441,449\xa0\n\xa0 \xa0 \xa0(3) 재평가잉여금\xa0\n\u3000\n33,300,719\xa0\n5,997,379\xa0\n\xa0 \xa0 \xa0(4) 순확정급여부채의 재측정요소\xa0\n\u3000\n-2,704,819,126\xa0\n4,994,070,506\xa0\n\xa0 XI. 연결총포괄손익\xa0\n\u3000\n4,818,327,262\xa0\n843,136,806,629\xa0\n\xa0 \xa01. 지배주주지분총포괄손익\n\u3000\n4,818,327,262\xa0\n843,136,806,629\xa0\n\xa0 \xa02. 비지배주주지분총포괄손익\n\u3000\n0\xa0\n0\xa0\n기본 및 희석주당이익\n\u3000\n960\xa0\n416\xa0\n주) 제35기는 2023년부터 적용되는 기업회계기준서 제1117호(보험계약) 및 제1109호(금융상품) 기준으로 작성되었고 제34기는 기업회계기준서 제1117호(보험계약) 및 제1039호(금융상품) 기준으로 작성\n다. 연결현금흐름표\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 현 금 흐 름 표\n제35기 1분기 (2023. 01. 01 ~ 2023. 3. 31)\n제34기 1분기 (2022. 01. 01 ~ 2022. 3. 31)\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과목\n제35기 1분기\xa0\n제34기 1분기\n\xa0Ⅰ. 영업활동으로 인한 현금흐름\xa0\n936,356,303,430\xa0\n-657,509,145,447\xa0\n\xa0 \xa01. 연결분기순이익\xa0\n149,572,155,565\xa0\n64,828,292,414\xa0\n\xa0 \xa02. 손익조정항목\xa0\n-40,947,771,135\xa0\n-80,287,445,433\xa0\n\xa0 \xa03. 자산ㆍ부채의 변동\xa0\n488,230,879,221\xa0\n-834,447,574,385\xa0\n\xa0 \xa04. 이자수취액\xa0\n216,704,610,608\xa0\n199,667,630,151\xa0\n\xa0 \xa05. 이자지급액\xa0\n-31,741,972,120\xa0\n-1,541,832,654\xa0\n\xa0 \xa06. 배당금수취액\xa0\n-4,288,220,389\xa0\n25,323,908,811\xa0\n\xa0 \xa07. 법인세환급(납부)액\xa0\n158,826,621,680\xa0\n-31,052,124,351\xa0\n\xa0Ⅱ. 투자활동으로 인한 현금흐름\xa0\n-1,257,194,373,688\xa0\n267,585,322,612\xa0\n\xa0 \xa01. 기타포괄손익-공정가치측정금융자산의 취득\n-1,309,872,466,227\xa0\n0\xa0\n\xa0 \xa02. 매도가능금융자산의 취득\xa0\n0\xa0\n-828,742,453,581\xa0\n\xa0 \xa03. 기타포괄손익-공정가치측정금융자산의 처분\n154,699,806,078\xa0\n0\xa0\n\xa0 \xa04. 매도가능금융자산의 처분\xa0\n0\xa0\n1,171,071,962,875\xa0\n\xa0 \xa05. 만기보유금융자산의 취득\xa0\n0\xa0\n-86,936,187,002\xa0\n\xa0 \xa06. 만기보유금융자산의 상환\xa0\n0\xa0\n156,285,412,582\xa0\n\xa0 \xa07. 위험회피목적파생상품의 정산\xa0\n-1,837,243,544\xa0\n-92,960,753,885\xa0\n\xa0 \xa08. 관계기업투자자산의 취득\xa0\n-100,488,842,336\xa0\n-50,000,000,000\xa0\n\xa0 \xa09. 유형자산의 취득\xa0\n-762,698,650\xa0\n-887,118,140\xa0\n\xa0 \xa010. 유형자산의 처분\xa0\n157,704,839\xa0\n3,956,451\xa0\n\xa0 \xa011. 투자부동산의 취득\n-21,999,978\xa0\n0\xa0\n\xa0 \xa012. 무형자산의 취득\xa0\n0\xa0\n-243,280,055\xa0\n\xa0 \xa013. 무형자산의 처분\xa0\n0\xa0\n12,564,167\xa0\n\xa0 \xa014. 선급금의 증가\n-18,562,500\xa0\n0\xa0\n\xa0 \xa015. 임차보증금의 증가\xa0\n-1,300,967,460\xa0\n-816,700,460\xa0\n\xa0 \xa016. 임차보증금의 감소\xa0\n2,250,896,090\xa0\n797,919,660\xa0\n\xa0Ⅲ. 재무활동으로 인한 현금흐름\xa0\n-13,483,306,459\xa0\n-13,465,029,334\xa0\n\xa0 \xa01. 임대보증금의 증가\xa0\n0\xa0\n243,729,000\xa0\n\xa0 \xa02. 임대보증금의 감소\xa0\n-83,833,000\xa0\n-847,008,000\xa0\n\xa0 \xa03. 자기주식의 처분\n139,343,250\xa0\n0\xa0\n\xa0 \xa04. 리스부채 원금 지급\xa0\n-3,258,383,761\xa0\n-3,197,152,320\xa0\n\xa0 \xa05. 신종자본증권 배당\xa0\n-10,280,432,948\xa0\n-9,664,598,014\xa0\nⅣ. 외화표시 현금및현금성자산에 대한 환율변동효과\n-27,665\xa0\n-601,330,429\xa0\nⅤ. 현금및현금성자산의 증가(Ⅰ+Ⅱ+Ⅲ+Ⅳ)\n-334,321,404,382\xa0\n-403,990,182,598\xa0\nⅥ. 기초의 현금및현금성자산\n602,036,177,820\xa0\n750,549,276,841\xa0\nⅦ. 분기말의 현금및현금성자산\n267,714,773,438\xa0\n346,559,094,243\xa0\n주) 제35기는 2023년부터 적용되는 기업회계기준서 제1117호(보험계약) 및 제1109호(금융상품) 기준으로 작성되었고 제34기는 기업회계기준서 제1117호(보험계약) 및 제1039호(금융상품) 기준으로 작성\n라. 연결자본변동표 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 연 결 자 본 변 동 표\n제35기 1분기 (2023. 01. 01 ~ 2023. 3. 31)\n제34기 1분기 (2022. 01. 01 ~ 2022. 3. 31)\n동양생명보험주식회사와 그 종속회사\n(단위 : 원)\n과목\n자본금\n연결자본잉여금\n신종자본증권\n연결자본조정\n연결기타포괄 손익누계액\n연결이익잉여금\n지배주주지분소계\n비지배지분\n총계\n2022년 1월 1일 (전기초)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n177,612,835,170\n1,312,036,706,045\n3,043,935,891,765\n-\n3,043,935,891,765\n\xa0 기업회계기준서 제1117호 최초 적용에 따른 조정\n-\n-\n-\n-\n38,848,703,592\n594,548,484,183\n633,397,187,775\n-\n633,397,187,775\n2022년 1월 1일 (조정후)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n216,461,538,762\n1,906,585,190,228\n3,677,333,079,540\n-\n3,677,333,079,540\n자본에 직접 반영된 소유주와의 거래 등 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연차배당\n-\n-\n-\n-\n-\n-96,632,322,700\n-96,632,322,700\n-\n-96,632,322,700\n\xa0 신종자본증권배당\n-\n-\n-\n-\n-\n-9,664,598,014\n-9,664,598,014\n-\n-9,664,598,014\n연결총포괄이익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연결분기순이익\n-\n-\n-\n-\n-\n64,828,292,414\n64,828,292,414\n-\n64,828,292,414\n\xa0 매도가능금융자산평가손익\n-\n-\n-\n-\n-424,609,185,693\n-\n-424,609,185,693\n-\n-424,609,185,693\n\xa0 만기보유금융자산평가손익\n-\n-\n-\n-\n-3,583,302,992\n-\n-3,583,302,992\n-\n-3,583,302,992\n\xa0 현금흐름위험회피파생상품평가손익\n-\n-\n-\n-\n252,493,566\n-\n252,493,566\n-\n252,493,566\n\xa0 보험계약금융손익\n-\n-\n-\n-\n1,201,248,441,449\n-\n1,201,248,441,449\n-\n1,201,248,441,449\n\xa0 재평가잉여금\n-\n-\n-\n-\n5,997,379\n-\n5,997,379\n-\n5,997,379\n\xa0 확정급여제도의 재측정요소\n-\n-\n-\n-\n4,994,070,506\n-\n4,994,070,506\n-\n4,994,070,506\n2022년 3월 31일 (전분기말)\n806,792,925,000\n463,680,391,349\n344,619,036,991\n-60,806,002,790\n994,770,052,977\n1,865,116,561,928\n4,414,172,965,455\n-\n4,414,172,965,455\n2023년 1월 1일 (당기초)\n806,792,925,000\n463,680,391,349\n344,572,058,588\n-60,806,002,790\n1,526,855,429,597\n1,778,495,002,383\n4,859,589,804,127\n-\n4,859,589,804,127\n기업회계기준서 제1109호 최초 적용에 따른 조정\n-\n-\n-\n-\n-1,152,025,109,788\n-715,032,649,653\n-1,867,057,759,441\n-\n-1,867,057,759,441\n2023년 1월 1일 (조정후)\n806,792,925,000\n463,680,391,349\n344,572,058,588\n-60,806,002,790\n374,830,319,809\n1,063,462,352,730\n2,992,532,044,686\n-\n2,992,532,044,686\n자본에 직접 반영된 소유주와의 거래 등 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 세율변동효과\n-\n-\n-4,697,841\n-\n-\n-\n-4,697,841\n-\n-4,697,841\n\xa0 신종자본증권배당\n-\n-\n-\n-\n-\n-10,280,432,948\n-10,280,432,948\n-\n-10,280,432,948\n\xa0 자기주식처분\n-\n-\n-\n139,343,250\n-\n-\n139,343,250\n-\n139,343,250\n연결총포괄손익 :\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 연결분기순이익\n-\n-\n-\n-\n-\n149,572,155,565\n149,572,155,565\n-\n149,572,155,565\n\xa0 기타포괄손익-공정가치측정채무증권평가손익\n-\n-\n-\n-\n384,032,501,937\n-\n384,032,501,937\n-\n384,032,501,937\n\xa0 현금흐름위험회피파생상품평가손익\n-\n-\n-\n-\n18,998,585,929\n-\n18,998,585,929\n-\n18,998,585,929\n\xa0 기타포괄손익-공정가치측정지분증권평가손익\n-\n-\n-\n-\n-35,831,480\n-\n-35,831,480\n-\n-35,831,480\n\xa0 보험계약금융손익\n-\n-\n-\n-\n-545,077,566,282\n-\n-545,077,566,282\n-\n-545,077,566,282\n\xa0 재평가잉여금\n-\n-\n-\n-\n33,300,719\n-\n33,300,719\n-\n33,300,719\n\xa0 순확정급여부채의 재측정요소\n-\n-\n-\n-\n-2,704,819,126\n-\n-2,704,819,126\n-\n-2,704,819,126\n2023년 3월 31일 (당분기말)\n806,792,925,000\n463,680,391,349\n344,567,360,747\n-60,666,659,540\n230,076,491,506\n1,202,754,075,347\n2,987,204,584,409\n-\n2,987,204,584,409\n주) 제35기는 2023년부터 적용되는 기업회계기준서 제1117호(보험계약) 및 제1109호(금융상품) 기준으로 작성되었고 제34기는 기업회계기준서 제1117호(보험계약) 및 제1039호(금융상품) 기준으로 작성\n']"
